UBS
-
Schmassmann and Sung will jointly steer the team in their newly created positions -
The Swiss online pharmacy sold a new convertible bond despite an 83% fall in its stock this year
-
The Swiss medical company said it opted for a direct listing for tax purposes
-
The firm priced its share at HK$158, with the top 15 investors taking around 70% of the offer
-
Hong Kong's largest IPO of the year is anchored by nine cornerstone investors
-
Decent sizes available in Swiss francs for high quality offshore names
-
Chinese duty-free retail chain prepares for largest listing of the year in Hong Kong
-
Although the spread between Pfandbriefe and cantonal bank paper has widened, both still remain attractive
-
Tight strategies amid high volatility appear to be working, with the exception of Credit Suisse which reported losses
-
UBS joins UK lender for post-earnings dollar market visit
-
A cloud computing giant, a fruit distributor, and trio of medical companies seek IPOs
-
Chinese property developer's shares sunk after fleeting rally
